NASDAQ NMS - GLOBAL MARKET · ASTH
+2.91% · +$1.23 · Vol 684.1K
Market closed · last close 4:00 PM ET · price as of 19:00:10 ET
Astrana Health Inc

Astrana Health Inc

Health Care
$43.50

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ASTH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Astrana Health Inc
SERVICES-MANAGEMENT CONSULTING SERVICES
Listed since
2007
Employees
3K
Country
US

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$42.67
Day high
$43.74
Day low
$41.82
Previous close
$42.27
52W high
$43.74
-0.55% from high
52W low
$37.87
96% of range
Market cap
$2.1B
P/E
69.05×
EPS
$0.6300
Shares out
49.6M
Volume
684.1K
VWAP
$43.16
Price history computed in-house
1W
+11.05%
SMA 50 $39.68 · above
SMA 200 $39.68 · above
52W position 96%
Veridion warehouse edge

Warehouse intelligence for ASTH.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ASTH insider activity

Astrana Health Inc

Score
Coverage building
Pressure
Net selling
Filings
31
Buys / sells
10 / 21
Net value
-$1.9M
Insiders
11
Named filers
BC
Basho Chandan
Insider
Leadership
KM
Kumar Dinesh M.
Insider
Leadership
SG
Sobotka Glenn
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$1.9M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-182026-05-16Basho ChandanInsidersell$38.268,155159,610$312KSEC Form 4
2026-04-152026-04-14Basho ChandanInsidersell$29.073,870167,765$113KSEC Form 4
2026-04-032026-04-02Basho ChandanInsidersell$25.052,092171,635$52KSEC Form 4
2026-04-032026-04-01Kumar Dinesh M.Insidersell$24.5157,980177,655$1.4MSEC Form 4
2026-03-302026-03-26Sobotka GlennInsidersell$24.2766214,039$16KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 26 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ASTH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ASTH in this window.
Lobbying spend

ASTH lobbying filings, year to date.

Registered lobbying filings matched to Astrana Health Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ASTH in this window.
Latest news · ASTH
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ASTH.
Options
Sovereign unlock shows live options positioning for ASTH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.